Neutropenia after the coadministration of clozapine and nirmatrelvir-ritonavir in a patient with SARS-CoV-2 infection: A case report with a literature review

Neutropenia after the coadministration of clozapine and nirmatrelvir-ritonavir in a patient with SARS-CoV-2 infection: A case report with a literature review

BackgroundSchizophrenia is considered one of the major risk factors for mortality from SARS-CoV-2 infection. Early antiviral treatment is important to decrease the risk of mortality. Currently, Paxlovid (nirmatrelvir-ritonavir) has been widely used in SARS-CoV-2 patients with risk factors. However,...

Full description

Bibliographic Details
Main Authors: Chun-I Liu, Kah Kheng Goh, Chun-Hsin Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Psychiatry
Subjects:
neutropenia
clozapine
SARS-CoV-2
drug-related side effects and adverse reactions
drug interactions
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1096006/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1096006/full

Similar Items